Literature DB >> 6355205

Is volume of distribution at steady state a meaningful kinetic variable?

D J Greenblatt, D R Abernethy, M Divoll.   

Abstract

Pharmacokinetic volumes of distribution (Vd) are commonly calculated either by the steady-state method (Vdss) or the area method (Vdarea). Vdss is traditionally perceived as the least biased and most reliable indicator of the extent of distribution, but Vdss in fact has far greater practical and theoretical limitation than does Vdarea. After single doses or multiple discrete doses of a drug, Vdarea correctly relates plasma concentration to amount of drug in the body at all times after distribution equilibrium is attained. Vdss, on the other hand, is a correct proportionality constant only during continuous intravenous infusion or at a single instant in time after discrete dosing. Furthermore, calculated values of Vdss are strongly dependent on the precise configuration of the initial distributional phase of the plasma concentration curve, which may be difficult or impossible to delineate because of variance arising from methodologic artefacts or unexplained causes. Such variance can lead to large nonphysiologic within- and between-individual variability in Vdss. Vdarea, on the other hand, is relatively independent or artefactual changes in the initial distribution profile. Finally, experimental observations indicate that elimination depends physiologically on distribution in the absence of changes in clearance, not the reverse. The relation of distribution and elimination holds whether the steady-state method or the area method is used to calculate Vd. Thus, Vdarea is a more reliable and generally valid descriptor of the extent of drug distribution than is Vdss.

Mesh:

Substances:

Year:  1983        PMID: 6355205     DOI: 10.1002/j.1552-4604.1983.tb02753.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  7 in total

Review 1.  Altered drug disposition following bariatric surgery: a research challenge.

Authors:  H Karl Greenblatt; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

2.  Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.

Authors:  C Y Lui; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

Review 3.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

4.  Lipid Nanosystems and Serum Protein as Biomimetic Interfaces: Predicting the Biodistribution of a Caffeic Acid-Based Antioxidant.

Authors:  Eduarda Fernandes; Sofia Benfeito; Fernando Cagide; Hugo Gonçalves; Sigrid Bernstorff; Jana B Nieder; M Elisabete Cd Real Oliveira; Fernanda Borges; Marlene Lúcio
Journal:  Nanotechnol Sci Appl       Date:  2021-02-09

5.  ADAM, a hands-on patient simulator for teaching principles of drug disposition and compartmental pharmacokinetics.

Authors:  Ines Zuna; Andrew Holt
Journal:  Br J Clin Pharmacol       Date:  2017-09-13       Impact factor: 4.335

6.  A Biophysical Insight of Camptothecin Biodistribution: Towards a Molecular Understanding of Its Pharmacokinetic Issues.

Authors:  Andreia Almeida; Eduarda Fernandes; Bruno Sarmento; Marlene Lúcio
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

7.  Tissue Distribution of Doxycycline in Animal Models of Tuberculosis.

Authors:  Martin Gengenbacher; Matthew D Zimmerman; Jansy P Sarathy; Firat Kaya; Han Wang; Marizel Mina; Claire Carter; Md Amir Hossen; Hongwei Su; Carolina Trujillo; Sabine Ehrt; Dirk Schnappinger; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.